Sort
21,281 grants matching “influenza”
Systems Approach to Immunity and Inflammation
$2,316,994Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2017 · AI
Robust T-cell Immunity to Influenza in Human Populations
$2,315,646Bloodcenter Of Wisconsin, Inc. · U19 · FY2005 · AI
Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center
$2,314,795Richard G Wunderink · Northwestern University At Chicago · U19 · FY2025 · AI
Strengthening the ISMMS research and response capabilities for pathogens of pandemic potential
$2,314,456Randy A. Albrecht · Icahn School Of Medicine At Mount Sinai · G20 · FY2022 · AI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$2,313,167Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$2,312,960Walter A. Orens · Emory University · N01 · FY2018 · AI
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$2,312,651Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
CEIRS Influenza Data Processing and Coordinating Center (DPCC)
$2,309,041Gillian Air · Digital Infuzion, Inc. · N01 · FY2018 · AI
NN/LM Region 6 RML and NN/LM Evaluation Office (NEO)
$2,305,954Tania P Bardyn · University Of Washington · UG4 · FY2018 · LM
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$2,303,802S. Mark Tompkins · University Of Georgia · N01 · FY2024 · AI
T Cell Costimulatory Pathways: Functions and Interactions
$2,299,983Arlene H Sharpe · Harvard Medical School · P01 · FY2015 · AI
Immune Function and Biodefense in Children, Elderly, and Immunocrompromised
$2,299,818Thomas Moran · Icahn School Of Medicine At Mount Sinai · N01 · FY2010 · AI
Advancing Public Health Research in Bangladesh
$2,298,943Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2019 · GH
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross
$2,298,830Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2021 · AI
Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment
$2,297,949Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2025 · AI
Inhibition of viral membrane fusion by interferon-induced proteins
$2,297,892Gregory B Melikian · Emory University · R01 · FY2025 · AI
Robust T-cell Immunity to Influenza in Human Populations
$2,292,639Bloodcenter Of Wisconsin, Inc. · U19 · FY2004 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
$2,292,123S. Mark Tompkins · University Of Georgia · N01 · FY2022 · AI
T Cell Costimulatory Pathways: Functions and Interactions
$2,292,094Arlene H Sharpe · Harvard Medical School · P01 · FY2016 · AI
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,288,273Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2025 · AG
T Cell Costimulatory Pathways: Functions and Interactions
$2,287,759Arlene H Sharpe · Harvard Medical School · P01 · FY2017 · AI
Molecular Center of Health and Disease
$2,283,750Michael R Garrett · University Of Mississippi Med Ctr · P20 · FY2023 · GM
Molecular Center of Health and Disease
$2,282,949Michael R Garrett · University Of Mississippi Med Ctr · P20 · FY2024 · GM
The Role of Pathogen-Environment Interactions in the Pandemic Potential of Influe
$2,282,173Linsey Marr · Virginia Polytechnic Inst And St Univ · DP2 · FY2013 · AI
Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center
$2,280,000Richard G Wunderink · Northwestern University At Chicago · U19 · FY2022 · AI